Anti-Pseudomonas Aeruginosa Antibody Staining

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to Dylight 633.

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to FITC.

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to HRP.

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to PE/ATTO 594.

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to PerCP.

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to RPE .

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is conjugated to Streptavidin.

Description: A polyclonal antibody for Metallothionein from Bacteria (Pseudomonas aeruginosa). The antibody is produced in rabbit after immunization with Pseudomonas aeruginosa Synthetic peptide from the mid-protein of Pseudomonas aeruginosa Metallothionein. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This Metallothionein antibody is unconjugated.

Description: This antibody is specific for serotype 5C and does not react with other species. Pseudomonas aeruginosa is a Gram-negative, aerobic, rod-shaped bacterium with unipolar motility. It is an opportunistic pathogen of plants and humans and can infect the urinary tract, respiratory and gastrointestinal system, soft tissues, bones and joints leading to severe systemic infections of immunosuppressed patients in hospitals. P. aeruginosa secretes a variety of pigments, including pyocyanin (blue-green), fluorescein (pyoverdin), and pyorubin (red-brown). This organism can achieve anaerobic growth with nitrate as a terminal electron acceptor, and, in its absence, it is also able to ferment arginine by substrate-level phosphorylation. Adaptation to microaerobic or anaerobic environments is essential for certain lifestyles of P. aeruginosa, such as during lung infection in cystic fibrosis patients where thick layers of alginate surrounding bacterial mucoid cells can limit the diffusion of oxygen.

Description: This antibody is specific for serotype 5C and does not react with other species. Pseudomonas aeruginosa is a Gram-negative, aerobic, rod-shaped bacterium with unipolar motility. It is an opportunistic pathogen of plants and humans and can infect the urinary tract, respiratory and gastrointestinal system, soft tissues, bones and joints leading to severe systemic infections of immunosuppressed patients in hospitals. P. aeruginosa secretes a variety of pigments, including pyocyanin (blue-green), fluorescein (pyoverdin), and pyorubin (red-brown). This organism can achieve anaerobic growth with nitrate as a terminal electron acceptor, and, in its absence, it is also able to ferment arginine by substrate-level phosphorylation. Adaptation to microaerobic or anaerobic environments is essential for certain lifestyles of P. aeruginosa, such as during lung infection in cystic fibrosis patients where thick layers of alginate surrounding bacterial mucoid cells can limit the diffusion of oxygen.

Description: This antibody is specific for serotype 5C and does not react with other species. Pseudomonas aeruginosa is a Gram-negative, aerobic, rod-shaped bacterium with unipolar motility. It is an opportunistic pathogen of plants and humans and can infect the urinary tract, respiratory and gastrointestinal system, soft tissues, bones and joints leading to severe systemic infections of immunosuppressed patients in hospitals. P. aeruginosa secretes a variety of pigments, including pyocyanin (blue-green), fluorescein (pyoverdin), and pyorubin (red-brown). This organism can achieve anaerobic growth with nitrate as a terminal electron acceptor, and, in its absence, it is also able to ferment arginine by substrate-level phosphorylation. Adaptation to microaerobic or anaerobic environments is essential for certain lifestyles of P. aeruginosa, such as during lung infection in cystic fibrosis patients where thick layers of alginate surrounding bacterial mucoid cells can limit the diffusion of oxygen.

Description: This antibody is specific for serotype 6C and does not react with other species. Pseudomonas aeruginosa is Gram-negative, aerobic, rod-shaped bacteria with unipolar motility. An opportunistic human pathogen, P. aeruginosa is also an opportunistic pathogen of plants. P. aeruginosa bacteria are clinically important because they are resistant to most antibiotics and they are capable of surviving in conditions that few other organisms can tolerate. Pseudomonas is often encountered in hospital and clinical work because it is a major cause of hospital acquired (nosocomial) infections. Its main targets are immuno-compromised individuals, burn victims, and individuals on respirators or with indwelling catheters. Additionally, these pathogens colonize the lungs of cystic fibrosis patients. P. aeruginosa is often identified by its pearlescent appearance and grape-like odor in vitro. Definitive clinical identification of P. aeruginosa includes identifying the production of both pyocyanin and fluorescein as well as its ability to grow at 42C. P. aeruginosa is capable of growth in diesel and jet fuel, where it is known as hydrocarbon utilizing microorganisms (or HUM bugs), causing microbial corrosion.

Description: This antibody is specific for serotype 6C and does not react with other species. Pseudomonas aeruginosa is Gram-negative, aerobic, rod-shaped bacteria with unipolar motility. An opportunistic human pathogen, P. aeruginosa is also an opportunistic pathogen of plants. P. aeruginosa bacteria are clinically important because they are resistant to most antibiotics and they are capable of surviving in conditions that few other organisms can tolerate. Pseudomonas is often encountered in hospital and clinical work because it is a major cause of hospital acquired (nosocomial) infections. Its main targets are immuno-compromised individuals, burn victims, and individuals on respirators or with indwelling catheters. Additionally, these pathogens colonize the lungs of cystic fibrosis patients. P. aeruginosa is often identified by its pearlescent appearance and grape-like odor in vitro. Definitive clinical identification of P. aeruginosa includes identifying the production of both pyocyanin and fluorescein as well as its ability to grow at 42C. P. aeruginosa is capable of growth in diesel and jet fuel, where it is known as hydrocarbon utilizing microorganisms (or HUM bugs), causing microbial corrosion.

Description: This antibody is specific for serotype 6C and does not react with other species. Pseudomonas aeruginosa is Gram-negative, aerobic, rod-shaped bacteria with unipolar motility. An opportunistic human pathogen, P. aeruginosa is also an opportunistic pathogen of plants. P. aeruginosa bacteria are clinically important because they are resistant to most antibiotics and they are capable of surviving in conditions that few other organisms can tolerate. Pseudomonas is often encountered in hospital and clinical work because it is a major cause of hospital acquired (nosocomial) infections. Its main targets are immuno-compromised individuals, burn victims, and individuals on respirators or with indwelling catheters. Additionally, these pathogens colonize the lungs of cystic fibrosis patients. P. aeruginosa is often identified by its pearlescent appearance and grape-like odor in vitro. Definitive clinical identification of P. aeruginosa includes identifying the production of both pyocyanin and fluorescein as well as its ability to grow at 42C. P. aeruginosa is capable of growth in diesel and jet fuel, where it is known as hydrocarbon utilizing microorganisms (or HUM bugs), causing microbial corrosion.